These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11121648)

  • 21. Influence of prostate volume on dosimetry results in real-time 125I seed implantation.
    McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer.
    Pellizzon AC; Salvajoli JV; Maia MA; Ferrigno R; Novaes PE; Fogarolli RC; Pellizzon RJ
    J Urol; 2004 Mar; 171(3):1105-8. PubMed ID: 14767280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity.
    Eapen L; Kayser C; Deshaies Y; Perry G; E C; Morash C; Cygler JE; Wilkins D; Dahrouge S
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1392-4. PubMed ID: 15275724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):81-8. PubMed ID: 14697424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS).
    Tanaka N; Yorozu A; Kikuchi T; Higashide S; Kojima S; Ohashi T; Katayama N; Nakamura K; Saito S; Dokiya T; Fukushima M;
    Brachytherapy; 2019; 18(4):484-492. PubMed ID: 31072729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First report on the use of a thinner (125)I radioactive seed within 20-gauge needles for permanent radioactive seed prostate brachytherapy: evaluation of postimplant dosimetry and acute toxicity.
    Sylvester J; Grimm P; Naidoo D; Bilik J; Miller A; Wong J
    Brachytherapy; 2013; 12(4):375-81. PubMed ID: 23415047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
    Kollmeier MA; Stock RG; Stone N
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):645-53. PubMed ID: 14529768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis.
    Shanahan TG; Nanavati PJ; Mueller PW; Maxey RB
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):490-6. PubMed ID: 12023154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
    Sarosdy MF
    Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?
    Stone NN; Marshall DT; Stone JJ; Cesaretti JA; Stock RG
    J Urol; 2010 Feb; 183(2):634-9. PubMed ID: 20018308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Review on the effectiveness of prostate cancer brachytherapy].
    Inciūra A; Jarusevicus L; Vaiciūnas K; Juozaityte E
    Medicina (Kaunas); 2009; 45(8):660-71. PubMed ID: 19773626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapy.
    Roeloffzen EM; Battermann JJ; van Deursen MJ; Monninkhof EM; Visscher MI; Moerland MA; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1072-9. PubMed ID: 20615621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
    Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy: our experience and literature review.
    Ikeda T; Shinohara K
    Int J Urol; 2009 Jun; 16(6):558-60. PubMed ID: 19456987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predicting for urinary incontinence after prostate brachytherapy.
    McElveen TL; Waterman FM; Kim H; Dicker AP
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1395-404. PubMed ID: 15275725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
    Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication.
    Chira C; Delouya G; Larrivée S; Carrier JF; Taussky D
    Radiat Oncol; 2013 Jul; 8():177. PubMed ID: 23837971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation.
    Brown D; Colonias A; Miller R; Benoit R; Cohen J; Arshoun Y; Galloway M; Karlovits S; Wu A; Johnson M; Quinn A; Kalnicki S
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):353-60. PubMed ID: 10802359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preimplant factors affecting prostate D90 after transperineal interstitial prostate brachytherapy with loose (125)I seeds.
    Sugawara A; Nakashima J; Kunieda E; Nagata H; Mizuno R; Takeda A; Seki S; Shiraishi Y; Kouta R; Oya M; Shigematsu N
    Keio J Med; 2012; 61(3):89-94. PubMed ID: 23018491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy.
    Schwartz DJ; Schild SE; Wong WW; Vora SA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):60-3. PubMed ID: 15629594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.